iPSCs Rejuvenate Cells but Pose Tumor Risks

D

Dr. Adeel Khan, regenerative medicine expert, in a podcast episode with Mark Hyman, MD.

Quotes From Source

“Induced pluripotent stem cells make old cells young again.”

Story of claim

Induced pluripotent stem cells (iPSCs) can rejuvenate old cells, but there is a risk of tumor formation, making them currently unsafe for clinical use.

  • Goal: To discuss the potential and risks of using iPSCs in cell rejuvenation.
  • Proof: iPSCs rejuvenate cells effectively but carry a significant risk of tumor growth.
  • Nuances:
    • Yamanaka stem cells can potentially cause cancer.
    • Clinical use of iPSCs is still years away.
  • Impact on Life: Promising for cell rejuvenation but current risks limit its application.

Investments

  • Price: Not applicable until further research
  • Time: Research phase; clinical application not available
  • Effort: Ongoing research required for safe clinical implementation

Risks

Potential for tumor growth makes iPSCs risky for clinical use.

Alternatives

  • Mitochondrial therapies
  • Other safer regenerative treatments

Get Started 🚀

  • Stay informed on iPSC research developments.
  • Explore current alternative rejuvenation therapies.
  • Consult with regenerative medicine experts for updates.

Brogevity AI can make mistakes. Check important info.

Reference Video